Plunkett Research Online: DBV Technologies SA

DBV TECHNOLOGIES SA (DBVTF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologic.....


DBV TECHNOLOGIES SA

Ticker: DBVTF
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 33 155427878
Fax: 33 143261083
Address: 177-181 avenue Pierre Brossolette
Montrouge, 92120 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologic.....See More See More

$USD, In whole numbers2020201920182017201620152014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture